Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FNA - Paragon 28, Inc.


Close
9.975
-0.045   -0.451%

Share volume: 2,361
Last Updated: Fri 27 Dec 2024 06:30:21 PM CET
Surgical and Medical Instrument Manufacturing : -0.07%

PREVIOUS CLOSE
CHG
CHG%

$10.02
-0.05
-0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 19%
Liquidity 34%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
1.78%
1 Month
2.91%
3 Months
59.47%
6 Months
63.54%
1 Year
-21.78%
2 Year
-51.35%
Key data
Stock price
$9.98
P/E Ratio 
-12.08
DAY RANGE
$9.96 - $10.37
EPS 
-$0.70
52 WEEK RANGE
$5.02 - $14.79
52 WEEK CHANGE
-$18.75
MARKET CAP 
695.072 M
YIELD 
N/A
SHARES OUTSTANDING 
83.542 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$618,030
AVERAGE 30 VOLUME 
$508,816
Company detail
CEO: Albert DaCosta
Region: US
Website: paragon28.com
Employees: 343,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems. It offers gorilla plating systems, including gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities.

Recent news